Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
The medical device manufacturer Owen Mumford has announced that it will stop producing its Autopen range of insulin delivery pens. Here, we look at what this means for people with diabetes who might ...
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
The companion app for the InPen digital insulin pen is designed to connect with the company’s latest Simplera continuous glucose monitor, offering users personalized dosing suggestions based on ...
The phasing out of pens for human insulin, an older form of the drug, comes as Novo boosts the production of another type of diabetes medicine, the appetite-reducing shot sold as Ozempic. Trouble is, ...
The regulatory clearance paves the way for the launch of the company’s “Smart MDI” system, including a smart insulin pen that tracks doses and a body worn monitor that makes real-time ...
They are calling for the Danish multinational to withdraw its decision to discontinue its provision of human insulin pens “in South Africa and other developing countries”. MSF also wants the ...
Some Part D plans cover Basaglar and other insulin pens. Unlike Medicare Part B ... A doctor may also be able to prescribe a different medication. If you have additional coverage, such as through ...
Each horse was placed into their individual holding pen 2 h prior to initiation of any sample ... animals supplemented with essential oils had a significantly lower insulin response compared to the ...